Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report of breastfeeding after maternal iodine contrast: neonatal hypothyroidism revealing an underlying congenital disorder. | Int Breastfeed J | 2026 | 41691276 | PubTator, text mining | PubMed |
| Pyrimidine-containing natural products: occurrences and biological activities. | Nat Prod Bioprospect | 2026 | 41634209 | PubTator, text mining | PubMed |
| Sex Differences in Response to Viral Vector Vaccines-Implications for Future Vaccine Design. | Immunol Rev | 2026 | 41612856 | PubTator, text mining | PubMed |
| A versatile platform for sequential glyco-, phospho-, and proteomics with multi-PTMs integration. | Nat Commun | 2026 | 41605919 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review. | J Enzyme Inhib Med Chem | 2026 | 41534849 | PubTator, text mining | PubMed |
| Targeting RSK2 enhances the efficacy of IGF1R inhibitor against triple-negative breast cancer via antagonizing IGF1/IGF1R signaling mediated by GATA3-IGFBP5 pathway. | Acta Pharmacol Sin | 2026 | 41501418 | PubTator, text mining | PubMed |
| Phosphorylation at S1288 of leukemia associated RhoGEF (LARG/ARHGEF12) induces plasma membrane localization and promotes binding and activation of RhoA. | J Biol Chem | 2026 | 41338458 | PubTator, text mining | PubMed |
| A 2-year-old girl with merged phenotypes: galactosemia and Coffin-Lowry syndrome. | J Pediatr Endocrinol Metab | 2026 | 41077643 | PubTator, text mining | PubMed |
| Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling. | Front Genet | 2025 | 41589305 | PubTator, text mining | PubMed |
| [Case Report of One Family With Coffin-Lowry Syndrome and Literature Review of 28 Cases in China]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536659 | PubTator, text mining | PubMed |
| RSK1 and RSK2 modulate the translatome of glioblastoma cells in an isoform-specific and mTORC1 independent manner. | Neurooncol Adv | 2025 | 41122673 | PubTator, text mining | PubMed |
| Phosphorylation of UDP-glucose dehydrogenase increases glycosaminoglycan biosynthesis and promotes tumor cell motility, spheroid growth, and therapeutic resistance. | Matrix Biol | 2025 | 41110727 | PubTator, text mining | PubMed |
| β-Fluorovinylsulfonamide as a Highly Reactivity- and Structure-Tunable Electrophile for Covalent Targeting of Proteins. | J Am Chem Soc | 2025 | 41034690 | PubTator, text mining | PubMed |
| A simple workflow to identify novel small linear motif (SLiM)-mediated interactions with AlphaFold. | Brief Bioinform | 2025 | 41016010 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Anticancer Action of Novel 2‑Hydroxy-1,4-naphthoquinone Thiol Derivatives. | ACS Omega | 2025 | 40978433 | PubTator, text mining | PubMed |
| The cytoplasmic domain of the pseudoprotease iRhom2 mediates distinct signaling mechanisms to control activation of the cell surface protease ADAM17. | J Biol Chem | 2025 | 40885391 | PubTator, text mining | PubMed |
| Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827. | Sci Adv | 2025 | 40845097 | PubTator, text mining | PubMed |
| Loss of Drosophila ribosomal protein S6 kinase II causes mitochondrial dysfunction and cell death. | Dis Model Mech | 2025 | 40827382 | PubTator, text mining | PubMed |
| Causal associations between fibroblast growth factors and breast cancer: Evidence from 2-sample Mendelian randomization analysis. | Medicine (Baltimore) | 2025 | 40826783 | PubTator, text mining | PubMed |
| Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer. | J Enzyme Inhib Med Chem | 2025 | 40762406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=2